Endocrinology, Vol 123, 1577-1581, Copyright © 1988 by Endocrine Society

ARTICLES

Induction of type II 5'-deiodinase activity by cyclic adenosine 3', 5'- monophosphate in cultured rat astroglial cells

F Courtin, F Chantoux, M Pierre and J Francon
Unite de Recherche sur la Glande Thyroide et la Regulation Hormonale, U.96 Institut National de la Sante et de la Recherche Medicale, Hopital de Bicetre, Le Kremlin-Bicetre, France.

Cultured astroglial cells were found to contain a type II 5'-deiodinase (5'D) activity which was increased by 10(-3) M (Bu)2cAMP but not by 2 X 10(-3) M n-butyrate. 8-Bromo-cAMP (8-Br-cAMP) (10(-3) M) also increased this enzyme activity. Cycloheximide (2 micrograms/ml) inhibited the 8- Br-cAMP effect on 5'D activity. Forskolin (10(-5) M), cholera toxin (5 micrograms/ml), 10(-5) M isoproterenol, and 3 X 10(-6) M norephinephrine also increased the 5'D activity of astroglial cells. After a 4-h incubation these agents or cAMP analogs had maximal effect, and enzyme activities were 6- to 14-fold above control value. The stimulatory effects of isoproterenol and norepinephrine were almost completely reversed after 8 h incubation. The induction of 5'D activity by isoproterenol or norepinephrine was inhibited by the beta-adrenergic antagonist alprenolol (5 X 10(-6) M). The effect of norepinephrine was not significantly affected by the alpha 1-adrenergic antagonist, prazosin (10(-5) M). Thus, 5'D activity is controlled by agents increasing cAMP in astroglial cells, and in particular by the neurotransmitter, norephinephrine, via a beta-adrenergic mechanism.

This article has been cited by other articles:

				A. Lamirand, S. Pallud-Mothre, M. Ramauge, M. Pierre, and F. Courtin Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes Endocrinology, July 1, 2008; 149(7): 3713 - 3721. [Abstract] [Full Text] [PDF]

				A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes Endocrinology, October 1, 2007; 148(10): 4745 - 4753. [Abstract] [Full Text] [PDF]

				A. G. Trentin Thyroid hormone and astrocyte morphogenesis. J. Endocrinol., May 1, 2006; 189(2): 189 - 197. [Abstract] [Full Text] [PDF]

				J. Grenier, A. Trousson, A. Chauchereau, J. Cartaud, M. Schumacher, and C. Massaad Differential Recruitment of p160 Coactivators by Glucocorticoid Receptor between Schwann Cells and Astrocytes Mol. Endocrinol., February 1, 2006; 20(2): 254 - 267. [Abstract] [Full Text] [PDF]

				R. Martinez-deMena and M.-J. Obregon Insulin increases the adrenergic stimulation of 5' deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K J. Mol. Endocrinol., February 1, 2005; 34(1): 139 - 151. [Abstract] [Full Text] [PDF]

				O. Araki, T. Morimura, T. Ogiwara, H. Mizuma, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Corticotropin-Secreting Mouse Pituitary Tumor Cells Is Stimulated by Glucocorticoid and Corticotropin-Releasing Hormone Endocrinology, October 1, 2003; 144(10): 4459 - 4465. [Abstract] [Full Text] [PDF]

				A. M. Lennon, M. Ramauge, A. Dessouroux, and M. Pierre MAP Kinase Cascades Are Activated in Astrocytes and Preadipocytes by 15-Deoxy-Delta 12-14-prostaglandin J2 and the Thiazolidinedione Ciglitazone through Peroxisome Proliferator Activator Receptor gamma -independent Mechanisms Involving Reactive Oxygenated Species J. Biol. Chem., August 9, 2002; 277(33): 29681 - 29685. [Abstract] [Full Text] [PDF]

				R. Martinez-deMena, A. Hernandez, and M.-J. Obregon Triiodothyronine is required for the stimulation of type II 5'-deiodinase mRNA in rat brown adipocytes Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1119 - E1127. [Abstract] [Full Text] [PDF]

				W. W. Li, C. Le Goascogne, M. Ramauge, M. Schumacher, M. Pierre, and F. Courtin Induction of Type 3 Iodothyronine Deiodinase by Nerve Injury in the Rat Peripheral Nervous System Endocrinology, December 1, 2001; 142(12): 5190 - 5197. [Abstract] [Full Text] [PDF]

				M. Murakami, O. Araki, T. Morimura, Y. Hosoi, H. Mizuma, M. Yamada, H. Kurihara, S. Ishiuchi, M. Tamura, T. Sasaki, et al. Expression of Type II Iodothyronine Deiodinase in Brain Tumors J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4403 - 4406. [Abstract] [Full Text]

				A. Guadano-Ferraz, M. J. Obregon, D. L. St. Germain, and J. Bernal The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain PNAS, September 16, 1997; 94(19): 10391 - 10396. [Abstract] [Full Text] [PDF]

				S. Pallud, A.-M. Lennon, M. Ramauge, J.-M. Gavaret, W. Croteau, M. Pierre, F. Courtin, and D. L. St. Germain Expression of the Type II Iodothyronine Deiodinase in Cultured Rat Astrocytes Is Selenium-dependent J. Biol. Chem., July 18, 1997; 272(29): 18104 - 18110. [Abstract] [Full Text] [PDF]